Khadim India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 9, 2025, 4:48 pm

Competitors of Khadim India Ltd

All Competitor Stocks of Khadim India Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:10 am

Below is a detailed analysis of the quarterly data for Khadim India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 95.70 Cr.. The value appears strong and on an upward trend. It has increased from 93.80 Cr. (Mar 2025) to 95.70 Cr., marking an increase of 1.90 Cr..
• For Expenses, as of Jun 2025, the value is 83.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.80 Cr. (Mar 2025) to 83.37 Cr., marking an increase of 5.57 Cr..
• For Operating Profit, as of Jun 2025, the value is 12.33 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2025) to 12.33 Cr., marking a decrease of 3.67 Cr..
• For OPM %, as of Jun 2025, the value is 12.88%. The value appears to be declining and may need further review. It has decreased from 17.06% (Mar 2025) to 12.88%, marking a decrease of 4.18%.
• For Other Income, as of Jun 2025, the value is 2.52 Cr.. The value appears strong and on an upward trend. It has increased from -1.54 Cr. (Mar 2025) to 2.52 Cr., marking an increase of 4.06 Cr..
• For Interest, as of Jun 2025, the value is 6.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.03 Cr. (Mar 2025) to 6.60 Cr., marking an increase of 0.57 Cr..
• For Depreciation, as of Jun 2025, the value is 6.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.82 Cr. (Mar 2025) to 6.77 Cr., marking a decrease of 0.05 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.48 Cr.. The value appears to be declining and may need further review. It has decreased from 1.61 Cr. (Mar 2025) to 1.48 Cr., marking a decrease of 0.13 Cr..
• For Tax %, as of Jun 2025, the value is 41.89%. The value appears to be increasing, which may not be favorable. It has increased from 37.27% (Mar 2025) to 41.89%, marking an increase of 4.62%.
• For Net Profit, as of Jun 2025, the value is 0.86 Cr.. The value appears to be declining and may need further review. It has decreased from 1.01 Cr. (Mar 2025) to 0.86 Cr., marking a decrease of 0.15 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.47. The value appears to be declining and may need further review. It has decreased from 0.55 (Mar 2025) to 0.47, marking a decrease of 0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:00 am

Growth

Last Updated: September 5, 2025, 9:05 am

Balance Sheet

Last Updated: December 4, 2025, 1:31 am

Below is a detailed analysis of the balance sheet data for Khadim India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
• For Reserves, as of Sep 2025, the value is 148.00 Cr.. The value appears to be declining and may need further review. It has decreased from 233.00 Cr. (Mar 2025) to 148.00 Cr., marking a decrease of 85.00 Cr..
• For Borrowings, as of Sep 2025, the value is 255.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 295.00 Cr. (Mar 2025) to 255.00 Cr., marking a decrease of 40.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 155.00 Cr.. The value appears to be improving (decreasing). It has decreased from 214.00 Cr. (Mar 2025) to 155.00 Cr., marking a decrease of 59.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 576.00 Cr.. The value appears to be improving (decreasing). It has decreased from 761.00 Cr. (Mar 2025) to 576.00 Cr., marking a decrease of 185.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 156.00 Cr.. The value appears to be declining and may need further review. It has decreased from 226.00 Cr. (Mar 2025) to 156.00 Cr., marking a decrease of 70.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 420.00 Cr.. The value appears to be declining and may need further review. It has decreased from 535.00 Cr. (Mar 2025) to 420.00 Cr., marking a decrease of 115.00 Cr..
• For Total Assets, as of Sep 2025, the value is 576.00 Cr.. The value appears to be declining and may need further review. It has decreased from 761.00 Cr. (Mar 2025) to 576.00 Cr., marking a decrease of 185.00 Cr..

However, the Borrowings (255.00 Cr.) are higher than the Reserves (148.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Khadim India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.76. This value is below the healthy minimum of 5. It has decreased from 3.49 (Mar 24) to 2.76, marking a decrease of 0.73.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.76. This value is below the healthy minimum of 5. It has decreased from 3.49 (Mar 24) to 2.76, marking a decrease of 0.73.
• For Cash EPS (Rs.), as of Mar 25, the value is 18.41. This value is within the healthy range. It has decreased from 25.76 (Mar 24) to 18.41, marking a decrease of 7.35.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 136.77. It has increased from 132.13 (Mar 24) to 136.77, marking an increase of 4.64.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 136.77. It has increased from 132.13 (Mar 24) to 136.77, marking an increase of 4.64.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 227.46. It has decreased from 339.09 (Mar 24) to 227.46, marking a decrease of 111.63.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 41.10. This value is within the healthy range. It has decreased from 44.10 (Mar 24) to 41.10, marking a decrease of 3.00.
• For PBIT / Share (Rs.), as of Mar 25, the value is 25.44. This value is within the healthy range. It has increased from 21.79 (Mar 24) to 25.44, marking an increase of 3.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.90. This value is within the healthy range. It has increased from 4.53 (Mar 24) to 11.90, marking an increase of 7.37.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.46 (Mar 24) to 2.75, marking a decrease of 0.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.46 (Mar 24) to 2.75, marking a decrease of 0.71.
• For PBDIT Margin (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 13.00 (Mar 24) to 18.06, marking an increase of 5.06.
• For PBIT Margin (%), as of Mar 25, the value is 11.18. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 11.18, marking an increase of 4.76.
• For PBT Margin (%), as of Mar 25, the value is 5.23. This value is below the healthy minimum of 10. It has increased from 1.33 (Mar 24) to 5.23, marking an increase of 3.90.
• For Net Profit Margin (%), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 5. It has increased from 1.02 (Mar 24) to 1.21, marking an increase of 0.19.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 8. It has increased from 1.02 (Mar 24) to 1.21, marking an increase of 0.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 15. It has decreased from 2.62 (Mar 24) to 2.01, marking a decrease of 0.61.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.11. This value is within the healthy range. It has increased from 9.39 (Mar 24) to 11.11, marking an increase of 1.72.
• For Return On Assets (%), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 5. It has decreased from 0.85 (Mar 24) to 0.66, marking a decrease of 0.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.45. This value is within the healthy range. It has decreased from 0.51 (Mar 24) to 0.45, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has decreased from 0.83 (Mar 24) to 0.56, marking a decrease of 0.27.
• For Current Ratio (X), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 24) which recorded 1.43.
• For Quick Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.79, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.04. This value is below the healthy minimum of 4. It has increased from 0.70 (Mar 24) to 2.04, marking an increase of 1.34.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.04. This value is within the healthy range. It has increased from 2.55 (Mar 24) to 3.04, marking an increase of 0.49.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 3. It has increased from 1.20 (Mar 24) to 1.77, marking an increase of 0.57.
• For Enterprise Value (Cr.), as of Mar 25, the value is 629.08. It has decreased from 660.38 (Mar 24) to 629.08, marking a decrease of 31.30.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.07 (Mar 24) to 1.50, marking an increase of 0.43.
• For EV / EBITDA (X), as of Mar 25, the value is 8.33. This value is within the healthy range. It has increased from 8.26 (Mar 24) to 8.33, marking an increase of 0.07.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has increased from 0.90 (Mar 24) to 1.26, marking an increase of 0.36.
• For Price / BV (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has decreased from 2.32 (Mar 24) to 2.10, marking a decrease of 0.22.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has increased from 0.90 (Mar 24) to 1.26, marking an increase of 0.36.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness